Vaxcyte, Inc. Share Price
NASDAQ: PCVX | Mid CapVaxcyte, Inc. Stock Performance
Open $59.41 | Prev. Close $58.90 | Circuit Range N/A |
Day Range $56.76 - $59.82 | Year Range $29.09 - $64.85 | Volume 29,135 |
Average Traded $58.38 |
Vaxcyte, Inc. Share Price Today
As of 9 August 2026, Vaxcyte, Inc.'s share price is $56.82. The stock opened at $59.41, compared to its previous close of $58.90. During today's trading session, Vaxcyte, Inc.'s share price traded between $56.76 and $59.82, with an average price of $58.29. Over the past 52 weeks, the stock has recorded a high of $64.85 and a low of $29.09. In terms of performance, Vaxcyte, Inc.'s share price has declined by 7.94% over the last six months and is up 84.54% on a year-on-year basis.
Vaxcyte, Inc. Share Price Chart
Vaxcyte, Inc. Stock Fundamentals & Key Indicators
Market Cap $7.73B | PE Ratio (TTM) -10.09 | Dividend Yield N/A |
EPS (TTM) $-5.63 | Revenue (TTM) N/A | Return On Equity (TTM) -28.55% |
Profit Margin N/A | Debt to Equity 0.08 | Quarterly Earnings Growth YoY -106.38% |
Vaxcyte, Inc. Quarterly Profit & Loss
All figures in USD
Vaxcyte, Inc. Annual Profit & Loss
All figures in USD
About Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Vaxcyte, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $54.01 | $56.82 | +5.09% |
Jul 2026 | $58.02 | $54.07 | -6.94% |
Jun 2026 | $50.45 | $58.10 | +12.98% |
May 2026 | $56.91 | $51.42 | -10.22% |
Apr 2026 | $58.69 | $57.28 | -1.34% |
Mar 2026 | $60.14 | $58.06 | -5.93% |
Feb 2026 | $53.59 | $61.72 | +15.11% |
Jan 2026 | $46.31 | $53.62 | +16.31% |
Dec 2025 | $44.98 | $46.10 | -6.84% |
Nov 2025 | $45.13 | $49.48 | +9.30% |
Oct 2025 | $36.17 | $45.27 | +25.69% |
Sep 2025 | $31.60 | $36.02 | +16.99% |
PCVX Share Price FAQs
What is Vaxcyte, Inc. share price today?
What is the 52 week high and 52 week low of Vaxcyte, Inc. stock?
What is PCVX's market capitalisation today?
What is PCVX's net income for the last quarter?
What is the 5 year returns of PCVX?
What is the high & low stock price of PCVX today?
Can I buy PCVX shares in India?